- Home
- ABOS vs CNDA Comparison
ABOS vs CNDA Comparison
Compare ABOS & CNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABOS
- CNDA
- Stock Information
- Founded
- ABOS 1996
- CNDA 2021
- Country
- ABOS United States
- CNDA United States
- Employees
- ABOS N/A
- CNDA N/A
- Industry
- ABOS Biotechnology: Pharmaceutical Preparations
- CNDA Blank Checks
- Sector
- ABOS Health Care
- CNDA Finance
- Exchange
- ABOS Nasdaq
- CNDA Nasdaq
- Market Cap
- ABOS 166.4M
- CNDA N/A
- IPO Year
- ABOS 2021
- CNDA 2021
- Fundamental
- Price
- ABOS $2.22
- CNDA $10.41
- Analyst Decision
- ABOS Strong Buy
- CNDA
- Analyst Count
- ABOS 4
- CNDA 0
- Target Price
- ABOS $9.00
- CNDA N/A
- AVG Volume (30 Days)
- ABOS 185.7K
- CNDA 17.3K
- Earning Date
- ABOS 08-13-2024
- CNDA 01-01-0001
- Dividend Yield
- ABOS N/A
- CNDA N/A
- EPS Growth
- ABOS N/A
- CNDA N/A
- EPS
- ABOS N/A
- CNDA 0.14
- Revenue
- ABOS N/A
- CNDA N/A
- Revenue This Year
- ABOS N/A
- CNDA N/A
- Revenue Next Year
- ABOS N/A
- CNDA N/A
- P/E Ratio
- ABOS N/A
- CNDA $30.54
- Revenue Growth
- ABOS N/A
- CNDA N/A
- 52 Week Low
- ABOS $1.81
- CNDA $10.22
- 52 Week High
- ABOS $5.76
- CNDA $10.65
- Technical
- Relative Strength Index (RSI)
- ABOS 32.70
- CNDA 40.87
- Support Level
- ABOS $2.73
- CNDA $10.07
- Resistance Level
- ABOS $2.92
- CNDA $10.75
- Average True Range (ATR)
- ABOS 0.19
- CNDA 0.06
- MACD
- ABOS -0.06
- CNDA 0.00
- Stochastic Oscillator
- ABOS 7.17
- CNDA 50.00
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.